LHC Group (NASDAQ:LHCG) Raised to “Buy” at BidaskClub

BidaskClub upgraded shares of LHC Group (NASDAQ:LHCG) from a hold rating to a buy rating in a report issued on Tuesday, April 10th.

A number of other equities research analysts have also commented on LHCG. Zacks Investment Research lowered LHC Group from a hold rating to a sell rating in a research report on Tuesday, January 9th. Stephens set a $74.00 target price on LHC Group and gave the company a buy rating in a research report on Friday, March 2nd. Jefferies Group reiterated a buy rating and issued a $84.00 target price on shares of LHC Group in a research report on Wednesday, April 4th. Finally, Craig Hallum upped their target price on LHC Group from $70.00 to $80.00 and gave the company a buy rating in a research report on Wednesday, April 4th. Two analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of Buy and an average price target of $76.80.

How to Become a New Pot Stock Millionaire

Shares of LHCG stock opened at $72.41 on Tuesday. LHC Group has a fifty-two week low of $51.38 and a fifty-two week high of $76.14. The stock has a market cap of $1,300.26, a PE ratio of 30.00, a price-to-earnings-growth ratio of 1.15 and a beta of 0.70. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.97 and a current ratio of 1.97.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, February 28th. The health services provider reported $0.62 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.62. The business had revenue of $292.40 million for the quarter, compared to analyst estimates of $280.82 million. LHC Group had a return on equity of 9.18% and a net margin of 4.67%. The company’s revenue was up 24.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.58 earnings per share. sell-side analysts predict that LHC Group will post 3.5 EPS for the current year.

In other LHC Group news, COO Donald Dwayne Stelly sold 14,216 shares of the company’s stock in a transaction that occurred on Tuesday, March 13th. The stock was sold at an average price of $64.00, for a total value of $909,824.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 14.80% of the company’s stock.

A number of institutional investors have recently added to or reduced their stakes in the business. American International Group Inc. boosted its position in LHC Group by 7.2% in the 3rd quarter. American International Group Inc. now owns 12,533 shares of the health services provider’s stock worth $889,000 after purchasing an additional 840 shares in the last quarter. OppenheimerFunds Inc. raised its stake in shares of LHC Group by 10.4% during the 4th quarter. OppenheimerFunds Inc. now owns 11,388 shares of the health services provider’s stock worth $698,000 after buying an additional 1,071 shares during the period. Cornercap Investment Counsel Inc. raised its stake in shares of LHC Group by 10.2% during the 4th quarter. Cornercap Investment Counsel Inc. now owns 11,845 shares of the health services provider’s stock worth $726,000 after buying an additional 1,095 shares during the period. Crossmark Global Holdings Inc. raised its stake in shares of LHC Group by 28.0% during the 4th quarter. Crossmark Global Holdings Inc. now owns 5,036 shares of the health services provider’s stock worth $308,000 after buying an additional 1,103 shares during the period. Finally, LS Investment Advisors LLC raised its stake in shares of LHC Group by 249.5% during the 4th quarter. LS Investment Advisors LLC now owns 2,478 shares of the health services provider’s stock worth $152,000 after buying an additional 1,769 shares during the period. Institutional investors and hedge funds own 89.91% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “LHC Group (NASDAQ:LHCG) Raised to “Buy” at BidaskClub” was originally reported by Week Herald and is owned by of Week Herald. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://weekherald.com/2018/04/18/lhc-group-lhcg-upgraded-to-buy-by-bidaskclub.html.

LHC Group Company Profile

LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply